A risk score based on the expression of CCNB2, DYNC1LI1, KIF11, SPC25, and KIF18A was constructed through stepwise regression and validated in TCGA and ICGC cohorts for predicting OS in HCC patients. This evidence concerns the gene CCNB2 and hepatocellular carcinoma.